As the U.S. stock market experiences a slight rebound, with major indices like the S&P 500 and Nasdaq Composite snapping their recent losing streaks, investors are keenly observing economic indicators and corporate earnings for signs of stability. In this environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.
Name | Current Price | Fair Value (Est) | Discount (Est) |
SouthState (NYSE:SSB) | $99.63 | $193.86 | 48.6% |
Argan (NYSE:AGX) | $132.20 | $264.33 | 50% |
MINISO Group Holding (NYSE:MNSO) | $20.69 | $41.15 | 49.7% |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | $30.63 | $59.48 | 48.5% |
Northwest Bancshares (NasdaqGS:NWBI) | $12.40 | $24.55 | 49.5% |
Old National Bancorp (NasdaqGS:ONB) | $23.40 | $45.50 | 48.6% |
Cadre Holdings (NYSE:CDRE) | $33.42 | $65.21 | 48.7% |
Array Technologies (NasdaqGM:ARRY) | $6.86 | $13.50 | 49.2% |
Albemarle (NYSE:ALB) | $77.53 | $151.62 | 48.9% |
DoubleVerify Holdings (NYSE:DV) | $21.59 | $42.15 | 48.8% |
Click here to see the full list of 182 stocks from our Undervalued US Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
Overview: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other diseases globally with a market cap of approximately $5.57 billion.
Operations: Lantheus Holdings generates revenue through its development, manufacturing, and commercialization of diagnostic and therapeutic products aimed at aiding clinicians in diagnosing and treating cardiovascular, oncological, and other medical conditions worldwide.
Estimated Discount To Fair Value: 47.9%
Lantheus Holdings, trading at US$93.25, is significantly undervalued with a fair value estimate of US$178.93. Analysts forecast its earnings to grow 19.8% annually, outpacing the U.S. market's 14.2%. Despite slower revenue growth at 11.4%, it still surpasses the market average of 8.8%. Recent guidance indicates revenue between US$1.545 billion and US$1.610 billion for 2025, following sales of US$1.53 billion in 2024 and strategic acquisitions enhancing its radiopharmaceutical capabilities.
Overview: Intuit Inc. offers financial management, compliance, and marketing products and services in the United States with a market cap of approximately $155.33 billion.
Operations: The company's revenue segments include Small Business & Self-Employed, Consumer, and Strategic Partner, focusing on financial management and compliance solutions.
Estimated Discount To Fair Value: 26.3%
Intuit, priced at US$625.51, is trading over 26% below its estimated fair value of US$849.26, with earnings anticipated to grow 16.5% annually, surpassing the U.S. market's 14.2%. Recent Q2 results show revenue growth from US$3.39 billion to US$3.96 billion year-over-year and net income rising from US$353 million to US$471 million, despite significant insider selling in the past quarter and ongoing share buybacks totaling $7.72 billion since 2018.
Overview: KE Holdings Inc. operates an integrated online and offline platform for housing transactions and services in China, with a market cap of approximately $25.45 billion.
Operations: The company's revenue segments include CN¥28.15 billion from new home transaction services, CN¥14.30 billion from home renovation and furnishing, CN¥25.33 billion from existing home transaction services, and CN¥8.91 billion from emerging and other services excluding home renovation and furnishing.
Estimated Discount To Fair Value: 13.4%
KE Holdings, currently priced at US$22.87, is trading 13.4% below its estimated fair value of US$26.42. Although profit margins have decreased from 7.5% to 5%, earnings are projected to grow significantly by over 21% annually, outpacing the U.S. market's growth rate of 14.2%. Despite substantial insider selling recently and low future return on equity forecasts, revenue growth is expected to exceed the broader market's pace at 11.4% annually.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:LNTH NasdaqGS:INTU and NYSE:BEKE.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。